GEODE CAPITAL MANAGEMENT, LLC
Position in COLL — Collegium Pharmaceutical, Inc
CIK 1214717
BOSTON, MA
Position in COLL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$32,250,072
+$5,151,193 QoQ
Shares Held
890,886
+8.7% QoQ
Ownership
2.74%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 280 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. COLL ranks #22 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
13,289,622 | $954,992,236 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
996,598 | $539,986,694 | |
| 3 | VTRS |
Viatris Inc
|
32,807,906 | $520,989,547 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,607,196 | $393,251,799 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,138,777 | $360,469,474 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,302,057 | $278,143,622 | |
| 7 | ALKS |
Alkermes plc.
|
4,477,876 | $234,640,702 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,841,367 | $204,281,254 |
All Filings in COLL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,250,072 | 890,886 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $27,098,879 | 819,440 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $38,403,673 | 829,453 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $29,264,970 | 836,381 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $23,071,785 | 780,243 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $22,851,189 | 765,534 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $22,074,280 | 770,481 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $29,968,372 | 775,579 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $24,797,702 | 770,115 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $28,476,333 | 733,548 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $22,508,367 | 731,266 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $15,888,257 | 710,884 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $14,821,524 | 689,694 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $15,430,080 | 643,188 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,358,874 | 618,917 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,703,185 | 605,692 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,691,999 | 603,386 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $12,431,917 | 610,605 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $11,303,959 | 605,137 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $12,053,105 | 610,593 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $14,708,855 | 622,202 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $13,894,717 | 586,275 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $10,529,530 | 525,688 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $10,536,190 | 506,061 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $8,889,352 | 507,963 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $7,967,537 | 487,908 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||